Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities

Raymond Duch; Laurence S. J. Roope; Mara Violato; Matias Fuentes Becerra; Thomas S. Robinson; Jean-francois Bonnefon; Jorge Friedman; Peter John Loewen; Pavan Mamidi; Alessia Melegaro; Mariana Blanco; Juan Vargas; Julia Seither; Paolo Candio; Ana Gibertoni Cruz; Xinyang Hua; Adrian Barnett; Philip M. Clarke

doi:10.1073/pnas.2026382118

Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities

Raymond Duch, Laurence S. J. Roope, Mara Violato, Matias Fuentes Becerra, Thomas S. Robinson, Jean-francois Bonnefon, Jorge Friedman, Peter John Loewen, Pavan Mamidi, Alessia Melegaro, Mariana Blanco, Juan Vargas, Julia Seither, Paolo Candio, Ana Gibertoni Cruz, Xinyang Hua, Adrian Barnett, Philip M. Clarke

Applied Health Sciences

Research output: Contribution to journal › Article › peer-review

36 Downloads (Pure)

Abstract

How does the public want a COVID-19 vaccine to be allocated? We conducted a conjoint experiment asking 15,536 adults in 13 countries to evaluate 248,576 profiles of potential vaccine recipients who varied randomly on five attributes. Our sample includes diverse countries from all continents. The results suggest that in addition to giving priority to health workers and to those at high risk, the public favors giving priority to a broad range of key workers and to those with lower income. These preferences are similar across respondents of different education levels, incomes, and political ideologies, as well as across most surveyed countries. The public favored COVID-19 vaccines being allocated solely via government programs but were highly polarized in some developed countries on whether taking a vaccine should be mandatory. There is a consensus among the public on many aspects of COVID-19 vaccination, which needs to be taken into account when developing and communicating rollout strategies.

Original language	English
Article number	e2026382118
Number of pages	10
Journal	Proceedings of the National Academy of Sciences of the United States of America
Volume	118
Issue number	38
Early online date	15 Sept 2021
DOIs	https://doi.org/10.1073/pnas.2026382118
Publication status	Published - 21 Sept 2021

Bibliographical note

Funding Information:
The research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre and the COVID-19 Oxford Vaccine Trial. R.D. acknowledges the support provided by Fondo Nacional de Desarrollo Cient?fico y Tecnol?gico 2020 Grant 1201397. M.V. received funding from the NIHR Applied Research Collaboration Oxford and Thames Valley at Oxford Health National Health Service (NHS) Foundation Trust. J.-F.B. acknowledges support from Investissements d?Avenir Grant ANR-17-EURE-0010. J.F. received funding from University of Santiago Project Dicyt USA1899. A.M. acknowledges support from Italian Ministry of Education Progetti di Rilevante Interesse Nazionale Grant 20177BRJXS and the European Research Council Consolidator Grant 101003183. We acknowledge the support of the Office of the Dean of the Faculty of Arts & Science at the University of Toronto. We are grateful to Professor Dominik Hangartner for his generous support and helpful suggestions. We also thank Teresa Day, Barbara Kitchener, and Melanie Sawers for their administrative support throughout the project. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care.

Publisher Copyright:
© 2021 National Academy of Sciences. All rights reserved.

Keywords

COVID-19
Public health
Public opinion
Vaccinations

ASJC Scopus subject areas

General

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1073/pnas.2026382118Licence: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

DuchR2021CitizensFinal published version, 812 KBLicence: Creative Commons: Attribution-NonCommercial-NoDerivs (CC BY-NC-ND)

Cite this

Duch, R., Roope, L. S. J., Violato, M., Fuentes Becerra, M., Robinson, T. S., Bonnefon, J., Friedman, J., Loewen, P. J., Mamidi, P., Melegaro, A., Blanco, M., Vargas, J., Seither, J., Candio, P., Gibertoni Cruz, A., Hua, X., Barnett, A., & Clarke, P. M. (2021). Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities. Proceedings of the National Academy of Sciences of the United States of America, 118(38), Article e2026382118. https://doi.org/10.1073/pnas.2026382118

@article{eb24a522fd3f43cda4777bf2152ad6ed,

title = "Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities",

abstract = "How does the public want a COVID-19 vaccine to be allocated? We conducted a conjoint experiment asking 15,536 adults in 13 countries to evaluate 248,576 profiles of potential vaccine recipients who varied randomly on five attributes. Our sample includes diverse countries from all continents. The results suggest that in addition to giving priority to health workers and to those at high risk, the public favors giving priority to a broad range of key workers and to those with lower income. These preferences are similar across respondents of different education levels, incomes, and political ideologies, as well as across most surveyed countries. The public favored COVID-19 vaccines being allocated solely via government programs but were highly polarized in some developed countries on whether taking a vaccine should be mandatory. There is a consensus among the public on many aspects of COVID-19 vaccination, which needs to be taken into account when developing and communicating rollout strategies.",

keywords = "COVID-19, Public health, Public opinion, Vaccinations",

author = "Raymond Duch and Roope, {Laurence S. J.} and Mara Violato and {Fuentes Becerra}, Matias and Robinson, {Thomas S.} and Jean-francois Bonnefon and Jorge Friedman and Loewen, {Peter John} and Pavan Mamidi and Alessia Melegaro and Mariana Blanco and Juan Vargas and Julia Seither and Paolo Candio and {Gibertoni Cruz}, Ana and Xinyang Hua and Adrian Barnett and Clarke, {Philip M.}",

note = "Funding Information: The research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre and the COVID-19 Oxford Vaccine Trial. R.D. acknowledges the support provided by Fondo Nacional de Desarrollo Cient?fico y Tecnol?gico 2020 Grant 1201397. M.V. received funding from the NIHR Applied Research Collaboration Oxford and Thames Valley at Oxford Health National Health Service (NHS) Foundation Trust. J.-F.B. acknowledges support from Investissements d?Avenir Grant ANR-17-EURE-0010. J.F. received funding from University of Santiago Project Dicyt USA1899. A.M. acknowledges support from Italian Ministry of Education Progetti di Rilevante Interesse Nazionale Grant 20177BRJXS and the European Research Council Consolidator Grant 101003183. We acknowledge the support of the Office of the Dean of the Faculty of Arts & Science at the University of Toronto. We are grateful to Professor Dominik Hangartner for his generous support and helpful suggestions. We also thank Teresa Day, Barbara Kitchener, and Melanie Sawers for their administrative support throughout the project. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Publisher Copyright: {\textcopyright} 2021 National Academy of Sciences. All rights reserved. ",

year = "2021",

month = sep,

day = "21",

doi = "10.1073/pnas.2026382118",

language = "English",

volume = "118",

journal = "Proceedings of the National Academy of Sciences of the United States of America",

issn = "1091-6490",

publisher = "National Academy of Sciences",

number = "38",

}

Duch, R, Roope, LSJ, Violato, M, Fuentes Becerra, M, Robinson, TS, Bonnefon, J, Friedman, J, Loewen, PJ, Mamidi, P, Melegaro, A, Blanco, M, Vargas, J, Seither, J, Candio, P, Gibertoni Cruz, A, Hua, X, Barnett, A & Clarke, PM 2021, 'Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities', Proceedings of the National Academy of Sciences of the United States of America, vol. 118, no. 38, e2026382118. https://doi.org/10.1073/pnas.2026382118

TY - JOUR

T1 - Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities

AU - Duch, Raymond

AU - Roope, Laurence S. J.

AU - Violato, Mara

AU - Fuentes Becerra, Matias

AU - Robinson, Thomas S.

AU - Bonnefon, Jean-francois

AU - Friedman, Jorge

AU - Loewen, Peter John

AU - Mamidi, Pavan

AU - Melegaro, Alessia

AU - Blanco, Mariana

AU - Vargas, Juan

AU - Seither, Julia

AU - Candio, Paolo

AU - Gibertoni Cruz, Ana

AU - Hua, Xinyang

AU - Barnett, Adrian

AU - Clarke, Philip M.

N1 - Funding Information: The research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre and the COVID-19 Oxford Vaccine Trial. R.D. acknowledges the support provided by Fondo Nacional de Desarrollo Cient?fico y Tecnol?gico 2020 Grant 1201397. M.V. received funding from the NIHR Applied Research Collaboration Oxford and Thames Valley at Oxford Health National Health Service (NHS) Foundation Trust. J.-F.B. acknowledges support from Investissements d?Avenir Grant ANR-17-EURE-0010. J.F. received funding from University of Santiago Project Dicyt USA1899. A.M. acknowledges support from Italian Ministry of Education Progetti di Rilevante Interesse Nazionale Grant 20177BRJXS and the European Research Council Consolidator Grant 101003183. We acknowledge the support of the Office of the Dean of the Faculty of Arts & Science at the University of Toronto. We are grateful to Professor Dominik Hangartner for his generous support and helpful suggestions. We also thank Teresa Day, Barbara Kitchener, and Melanie Sawers for their administrative support throughout the project. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care. Publisher Copyright: © 2021 National Academy of Sciences. All rights reserved.

PY - 2021/9/21

Y1 - 2021/9/21

N2 - How does the public want a COVID-19 vaccine to be allocated? We conducted a conjoint experiment asking 15,536 adults in 13 countries to evaluate 248,576 profiles of potential vaccine recipients who varied randomly on five attributes. Our sample includes diverse countries from all continents. The results suggest that in addition to giving priority to health workers and to those at high risk, the public favors giving priority to a broad range of key workers and to those with lower income. These preferences are similar across respondents of different education levels, incomes, and political ideologies, as well as across most surveyed countries. The public favored COVID-19 vaccines being allocated solely via government programs but were highly polarized in some developed countries on whether taking a vaccine should be mandatory. There is a consensus among the public on many aspects of COVID-19 vaccination, which needs to be taken into account when developing and communicating rollout strategies.

AB - How does the public want a COVID-19 vaccine to be allocated? We conducted a conjoint experiment asking 15,536 adults in 13 countries to evaluate 248,576 profiles of potential vaccine recipients who varied randomly on five attributes. Our sample includes diverse countries from all continents. The results suggest that in addition to giving priority to health workers and to those at high risk, the public favors giving priority to a broad range of key workers and to those with lower income. These preferences are similar across respondents of different education levels, incomes, and political ideologies, as well as across most surveyed countries. The public favored COVID-19 vaccines being allocated solely via government programs but were highly polarized in some developed countries on whether taking a vaccine should be mandatory. There is a consensus among the public on many aspects of COVID-19 vaccination, which needs to be taken into account when developing and communicating rollout strategies.

KW - COVID-19

KW - Public health

KW - Public opinion

KW - Vaccinations

UR - http://www.scopus.com/inward/record.url?scp=85115334814&partnerID=8YFLogxK

U2 - 10.1073/pnas.2026382118

DO - 10.1073/pnas.2026382118

M3 - Article

SN - 1091-6490

VL - 118

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

IS - 38

M1 - e2026382118

ER -

Citizens from 13 countries share similar preferences for COVID-19 vaccine allocation priorities

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Fingerprint

Cite this